Recross Cardio, Inc.
Clinical trials sponsored by Recross Cardio, Inc., explained in plain language.
-
New heart device aims to seal Stroke-Causing hole
Disease control Recruiting nowThis trial tests a new device called the P3 Occluder System designed to close a patent foramen ovale (PFO) — a small opening between the upper chambers of the heart. The study includes adults aged 18 to 65 who have had a stroke possibly linked to a PFO. Participants receive the i…
Phase: NA • Sponsor: Recross Cardio, Inc. • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
New heart device aims to prevent future strokes by closing a common hole
Disease control Recruiting nowThis study tests a new device (P3 Occluder) to close a small hole in the heart called a PFO in people who have had a stroke possibly linked to that hole. About 15 adults aged 18-65 will get the device and be followed for up to 5 years to see if it safely and effectively closes th…
Phase: NA • Sponsor: Recross Cardio, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC